These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32555667)

  • 1. Treatment of stimulant use disorder: A systematic review of reviews.
    Ronsley C; Nolan S; Knight R; Hayashi K; Klimas J; Walley A; Wood E; Fairbairn N
    PLoS One; 2020; 15(6):e0234809. PubMed ID: 32555667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.
    Chan B; Freeman M; Ayers C; Korthuis PT; Paynter R; Kondo K; Kansagara D
    Drug Alcohol Depend; 2020 Nov; 216():108193. PubMed ID: 32861136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
    Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
    PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications to treat cocaine use disorders: current options.
    Buchholz J; Saxon AJ
    Curr Opin Psychiatry; 2019 Jul; 32(4):275-281. PubMed ID: 31008728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression.
    Dell'Osso B; Ketter TA; Cremaschi L; Spagnolin G; Altamura AC
    Curr Psychiatry Rep; 2013 Aug; 15(8):378. PubMed ID: 23881710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial interventions for people with both severe mental illness and substance misuse.
    Hunt GE; Siegfried N; Morley K; Sitharthan T; Cleary M
    Cochrane Database Syst Rev; 2013 Oct; (10):CD001088. PubMed ID: 24092525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
    Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
    Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
    Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
    Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
    Chan E; Fogler JM; Hammerness PG
    JAMA; 2016 May; 315(18):1997-2008. PubMed ID: 27163988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond methylphenidate: nonstimulant medications for youth with ADHD.
    Wood JG; Crager JL; Delap CM; Heiskell KD
    J Atten Disord; 2007 Nov; 11(3):341-50. PubMed ID: 17932386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach.
    Tardelli VS; Berro LF; Gerra G; Tadonio L; Bisaga A; Fidalgo TM
    Addict Biol; 2023; 28(4):e13271. PubMed ID: 37016755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-review on the efficacy of psychological therapies for the treatment of substance use disorders.
    Dellazizzo L; Potvin S; Giguère S; Landry C; Léveillé N; Dumais A
    Psychiatry Res; 2023 Aug; 326():115318. PubMed ID: 37356250
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.